Recovery From Acute Kidney Injury With Diabetic Ketoacidosis Following SARS-CoV-2 Infection: A Case Report and Literature Review

Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes (DM) and sometimes type 2 diabetes. DKA in COVID-19 patients predicts a poor prognosis. There are few published reports describing DKA and AKI in COVID-19 patients. There is even less information on renal recovery or follow up of these patients. We report a case of a 55-year-old man with type 2 diabetes who presented with cough and shortness of breath. He was found to have DKA, AKI, and COVID-19. He was admitted to the ICU and subsequently intubated for airway protection and started on renal replacement therapy for AKI. The patient's renal function eventually recovered after 48 days of hospitalization, and he was discharged from the hospital. We report this case and performed a literature review to highlight that COVID-19 can lead to DKA and severe AKI in patients with DM. More importantly, we described the clinical and laboratory data that are associated with the recovery of COVID-19 AKI that are rarely reported.